XML 120 R94.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCK-BASED INCENTIVE PLANS - UNVESTED CASH AND STOCK-SETTLED RSUs, TSRIs & CROCEI (Details) - $ / shares
shares in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash-Settled RSUs      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 271    
Granted (in shares) 293    
Vested (in shares) (141)    
Forfeitures (in shares) (25)    
Unvested, end of period (in shares) 398 271  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 37.96    
Granted, weighted-average grant-date fair value (in dollars per share) 58.87 $ 60.43 $ 47.41
Vested, weighted-average grant-date fair value (in dollars per share) 43.61    
Forfeitures, weighted-average grant-date fair value (in dollars per share) 57.60    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 50.14 $ 37.96  
Stock-Settled RSUs      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 7,732    
Granted (in shares) 3,540    
Vested (in shares) (3,978)    
Forfeitures (in shares) (175)    
Unvested, end of period (in shares) 7,119 7,732  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 47.03    
Granted, weighted-average grant-date fair value (in dollars per share) 61.34 $ 59.85 $ 45.14
Vested, weighted-average grant-date fair value (in dollars per share) 40.37    
Forfeitures, weighted-average grant-date fair value (in dollars per share) 56.58    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 57.63 $ 47.03  
TSRIs      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 1,507    
Granted (in shares) 439    
Vested (in shares) (651)    
Forfeitures (in shares) (44)    
Unvested, end of period (in shares) 1,251 1,507  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 40.43    
Granted, weighted-average grant-date fair value (in dollars per share) 61.36    
Vested, weighted-average grant-date fair value (in dollars per share) 25.39    
Forfeitures, weighted-average grant-date fair value (in dollars per share) 55.30    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 55.08 $ 40.43  
Payout at vesting percentage 180.00%    
Issued (in shares) 1,172    
CROCEI awards      
Roll-forward of stock awards other than options and SARS.      
Unvested, beginning of period (in shares) 507    
Granted (in shares) 161    
Vested (in shares) (221)    
Unvested, end of period (in shares) 447 507  
Stock awards other than options and SARs, Weighted-Average Grant-Date Fair Value (in dollars per share)      
Unvested, beginning of period, weighted-average grant-date fair value (in dollars per share) $ 39.59    
Granted, weighted-average grant-date fair value (in dollars per share) 61.36    
Vested, weighted-average grant-date fair value (in dollars per share) 25.39    
Unvested, end of period, weighted-average grant-date fair value (in dollars per share) $ 54.55 $ 39.59  
Payout at vesting percentage 200.00%    
Issued (in shares) 441